Moderna | MRNA - Market Capitalization


Moderna reported $18.55B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Arrowhead Research USD 8.78B 236M Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Incyte USD 18.73B 660M Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.57B 225M Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025